Patents by Inventor Hua Shi

Hua Shi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170208395
    Abstract: A loudspeaker module comprising a module casing. A loudspeaker unit body (30) is accommodated within the module casing. The loudspeaker unit body (30) comprises a unit body front cover (32) and a unit body casing (34) which are combined with each other. A vibration system and a magnetic circuit system are accommodated within a space enclosed by the unit body front cover (32) and the unit body casing (34). A plurality of positioning columns (340) are arranged outside sidewalls of the unit body casing (34). Each of the positioning columns (340) protrudes out of the surface of the sidewall of the unit body casing (34), and extends from the upper end of the unit body casing (34) to the lower end of the unit body casing (34) along the sidewall of the unit body casing (34). Positioning bosses (22) are individually arranged at positions on the module casing corresponding to the positioning columns (340).
    Type: Application
    Filed: June 30, 2015
    Publication date: July 20, 2017
    Applicant: GOERTEK INC.
    Inventors: Ling WAN, Hua SHI
  • Publication number: 20170041693
    Abstract: Disclosed is a loudspeaker module applied inside a terminal, wherein, the terminal comprises a terminal housing, and the loudspeaker module is fixed inside the terminal. The loudspeaker module comprises a loudspeaker unit and a module housing for accommodating and fixing the loudspeaker unit. A closed space formed by the loudspeaker unit, an outer wall of the module housing, and the terminal housing is a rear sound cavity. By means of the loudspeaker module provided in the present invention, the usable space inside the terminal can be converted into the rear sound cavity, so that the space of the rear sound cavity is enlarged, and the acoustic performance of the loudspeaker module can be effectively improved. Therefore, the present invention makes full use of the inside space of the terminal to realize the thinning of the loudspeaker module without changing the inside space of the terminal, and achieves good acoustic performance.
    Type: Application
    Filed: March 26, 2015
    Publication date: February 9, 2017
    Applicant: GOERTEK INC.
    Inventors: Wei JIA, Hua SHI
  • Publication number: 20160150305
    Abstract: The present invention relates to the technical field of electro-acoustic products. Provided is a loudspeaker module, comprising a first cover (10) and a second cover (20) combined together; the first cover (10) and the second cover (20) enclose an inner cavity of the module; the inner cavity of the module houses a loudspeaker unit (30) therein; the loudspeaker module further comprises a fastener assembly used to fasten to a fixed structure of an electronic device and thus fix the loudspeaker module to the electronic device. The loudspeaker module solves the technical problem in the prior art of insecure engagement between a loudspeaker module and an electronic device. The loudspeaker module is securely engaged with the electronic device and is easy to install, thus effectively extending the service life of the electronic device installed with the loudspeaker module.
    Type: Application
    Filed: September 27, 2013
    Publication date: May 26, 2016
    Inventors: Ling WAN, Jingwei WANG, Hua SHI
  • Publication number: 20160000850
    Abstract: The invention provides a composition containing extracts from salvia miltiorrhiza bunge, gynostemma pentaphyllummak, Chinese magnoliavine, cordyceps extract piece, pollen pini, and semen persicae and methods of and using the same.
    Type: Application
    Filed: September 16, 2015
    Publication date: January 7, 2016
    Inventors: Ning Zhang, Cheng Rong Wang, Ping Liu, Hua Shi Bian, Jian Hua Zhang, Xiu Rong Yuan, Cheng Hai Liu, Yao Wang Jin, Hai Bo Ping
  • Patent number: 9138449
    Abstract: The invention provides a composition containing extracts from salvia miltiorrhiza bunge, gynostemma pentaphyllum mak, Chinese magnoliavine, cordyceps extract piece, pollen pini, and semen persicae and methods of and using the same.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: September 22, 2015
    Assignees: Shanghai Sundise Chinese Medicine Technology Development Co., Ltd., Shanghai Huanghai Pharmaceutical Co., Ltd.
    Inventors: Ning Zhang, Cheng Rong Wang, Ping Liu, Hua Shi Bian, Jian Hua Zhang, Xiu Rong Yuan, Cheng Hai Liu, Yao Wang Jin, Hai Bo Ping
  • Publication number: 20150031754
    Abstract: The present invention relates to a nucleic acid aptamer molecule that includes a domain that binds to an estrogen receptor, molecular complexes that include the nucleic acid aptamer molecule and an estrogen receptor, and constructed DMA molecules and expression systems, as well as host cells, that the contain an RNA aptamer molecule of the invention. Use of these aptamers and encoding constructs to inhibiting estrogen receptor activity in a cell and to treat estrogen receptor-positive cancers is also described.
    Type: Application
    Filed: August 16, 2012
    Publication date: January 29, 2015
    Applicant: RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK AT ALBANY
    Inventors: Hua Shi, Daiying Xu, Vamshee Krishna Chatakonda
  • Patent number: 8927509
    Abstract: This invention relates to nucleic acid aptamers that recognize and bind the complement protein C3 or its biologically active proteolytic products and methods of their use. Particularly preferred are bi-functional aptamer construct that binding specifically with C3b or iC3b, and another target protein. Use of these molecular constructs for commandeering the opsonization process is also described herein.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: January 6, 2015
    Assignee: The Research Foundation of State University of New York
    Inventors: Hua Shi, Albert J. T. Millis, Kimi Nishikawa, Prabhat Kumar Mallik
  • Patent number: 8450468
    Abstract: The present invention relates to novel nucleic acid ligands or aptamers that bind to and inhibit the activation of the ?-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors. Also disclosed is a novel combination of technologies, i.e., SELEX and laser pulse photolysis for the selection and screening of aptamers that inhibit receptor function and are useful therefore, in the treatment of diseases associated with excessive activation of ionotropic glutamate receptors.
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: May 28, 2013
    Assignees: The Research Foundation for the State University of New York, Cornell University
    Inventors: Li Niu, Zhen Huang, Hua Shi, John T. Lis
  • Patent number: 8445655
    Abstract: The present invention relates to a nucleic acid aptamer having a first domain that binds to a fluorescent protein. The nucleic acid aptamer forms a molecular complex whereby the aptamer binds a fluorescent protein at the first domain. A constructed DNA molecule, expression systems, and host cells containing the molecular complex are also disclosed. The invention also relates to a system containing a first DNA molecule encoding the nucleic acid aptamer of the present invention and a second DNA molecule encoding a fluorescent protein capable of being bound by the first domain. Methods of detecting a molecular target and determining location of a molecular target using the nucleic acid aptamer of the invention are also disclosed.
    Type: Grant
    Filed: June 18, 2007
    Date of Patent: May 21, 2013
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Michael Kotlikoff, John T. Lis, Bo Shui, Hua Shi
  • Publication number: 20120225929
    Abstract: The present invention relates to novel nucleic acid ligands or aptamers that bind to and inhibit the activation of the ?-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors. Also disclosed is a novel combination of technologies, i.e., SELEX and laser pulse photolysis for the selection and screening of aptamers that inhibit receptor function and are useful therefore, in the treatment of diseases associated with excessive activation of ionotropic glutamate receptors.
    Type: Application
    Filed: December 12, 2011
    Publication date: September 6, 2012
    Applicant: The Research Foundation of State University of New York
    Inventors: Li NIU, Zhen HUANG, Hua SHI, John T. LIS
  • Patent number: 8205174
    Abstract: An integrated circuit modeling method 100 implementable on computer, which has an executable software model 145 having modules 140 of reusable functional cores 105 coded in a high level language and a virtual platform of the integrated circuit employable in an architecture exploration step 115. A modeling library of modules coded in high level languages and hardware level languages are provided and instantiated according to user input in a functional verification step 120 having a co-simulation environment, with interface code 170 between modules automatically generated by an interface generator 130 based on a two dimensional data array of hardware specification inputs 205, the interface code 170 further interfacing with wrappers engaged between high and hardware level language modules.
    Type: Grant
    Filed: August 17, 2009
    Date of Patent: June 19, 2012
    Assignees: Hong Kong Applied Science and Technology Research, Institute Company Limited
    Inventors: Suet Fei Li, Yunzhao Lu, Erik Olsson, Ming Hua Shi
  • Publication number: 20120141382
    Abstract: This invention relates to nucleic acid aptamers that recognize and bind the complement protein C3 or its biologically active proteolytic products and methods of their use. Particularly preferred are bi-functional aptamer construct that binding specifically with C3b or iC3b, and another target protein. Use of these molecular constructs for commandeering the opsonization process is also described herein.
    Type: Application
    Filed: May 20, 2009
    Publication date: June 7, 2012
    Applicant: Research Foundation of State University of New York at Albany
    Inventors: Hua Shi, Albert J.T. Millis, Kimi Nishikawa, Prabhat Kumar Mallik
  • Patent number: 8193122
    Abstract: A seed crystal for the fabrication of a superconductor is grown from a rare-earth oxide having the basic formula XwZtBaxCuyOz, X comprising at least one rare-earth element and Z being a dopant which raises the peritectic decomposition temperature (Tp) of the oxide. In a preferred embodiment, the dopant is Mg. Use of this rare-earth oxide material for seed crystals increases the temperature at which cold-seeding can be performed and thus enables the growth of a wider range of bulk superconductor materials by this process.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: June 5, 2012
    Assignee: The Boeing Company
    Inventors: David Anthony Cardwell, Nadendla Hari Babu, Yun-Hua Shi
  • Publication number: 20120077367
    Abstract: A cable assembly comprises an insulative housing having a pair of positioning protrudings extending outwardly from the surface thereof, a plurality of conductive terminals received in the insulative housing, a cable having a number of wires electronically connected to the conductive terminals, a no metal cove having a receiving space surrounded by a plurality of walls for enclosing the insulative housing and a pair of positioning holes defined respectively on the surface of two walls, communicated with the receiving space and respectively receiving the positioning protrudings of the insulative housing.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 29, 2012
    Applicant: HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: PING-SHENG SU, YONG-HUA SHI, LI-ZHI HUANG
  • Publication number: 20110319268
    Abstract: A seed crystal for the fabrication of a superconductor is grown from a rare-earth oxide having the basic formula XwZtBaxCuyOz, X comprising at least one rare-earth element and Z being a dopant which raises the peritectic decomposition temperature (Tp) of the oxide. In a preferred embodiment, the dopant is Mg. Use to of this rare-earth oxide material for seed crystals increases the temperature at which cold-seeding can be performed and thus enables the growth of a wider range of bulk superconductor materials by this process.
    Type: Application
    Filed: June 30, 2011
    Publication date: December 29, 2011
    Applicant: Cambridge Enterprise Limited
    Inventors: David Anthony Cardwell, Nadendla Hari Babu, Yun-Hua Shi
  • Patent number: 8076467
    Abstract: The present invention relates to novel nucleic acid ligands or aptamers that bind to and inhibit the activation of the ?-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors. Also disclosed is a novel combination of technologies, i.e., SELEX and laser pulse photolysis for the selection and screening of aptamers that inhibit receptor function and are useful therefore, in the treatment of diseases associated with excessive activation of ionotropic glutamate receptors.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: December 13, 2011
    Assignees: The Research Foundation of State University of New York, Cornell University
    Inventors: Li Niu, Zhen Huang, Hua Shi, John T. Lis
  • Patent number: 8003072
    Abstract: A seed crystal for the fabrication of a superconductor is grown from a rare-earth oxide having the basic formula XwZtBaxCuyOz, X comprising at least one rare-earth element and Z being a dopant which raises the peritectic decomposition temperature (Tp) of the oxide. In a preferred embodiment, the dopant is Mg. Use of this rare-earth oxide material for seed crystals increases the temperature at which cold-seeding can be performed and thus enables the growth of a wider range of hulk superconductor materials by this process.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: August 23, 2011
    Assignee: Cambridge Enterprise Limited
    Inventors: David Anthony Cardwell, Nadendla Hari Babu, Yun-Hua Shi
  • Publication number: 20110041106
    Abstract: An integrated circuit modeling method 100 implementable on computer, which has an executable software model 145 having modules 140 of reusable functional cores 105 coded in a high level language and a virtual platform of the integrated circuit employable in an architecture exploration step 115. A modeling library of modules coded in high level languages and hardware level languages are provided and instantiated according to user input in a functional verification step 120 having a co-simulation environment, with interface code 170 between modules automatically generated by an interface generator 130 based on a two dimensional data array of hardware specification inputs 205, the interface code 170 further interfacing with wrappers engaged between high and hardware level language modules.
    Type: Application
    Filed: August 17, 2009
    Publication date: February 17, 2011
    Applicant: Hong Kong Applied Science and Technology Research Institute Company Limited
    Inventors: Suet Fei LI, Yunzhao LU, Erik OLSSON, Ming Hua SHI
  • Publication number: 20100099749
    Abstract: The present invention relates to novel nucleic acid ligands or aptamers that bind to and inhibit the activation of the ?-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors. Also disclosed is a novel combination of technologies, i.e., SELEX and laser pulse photolysis for the selection and screening of aptamers that inhibit receptor function and are useful therefore, in the treatment of diseases associated with excessive activation of ionotropic glutamate receptors.
    Type: Application
    Filed: October 13, 2009
    Publication date: April 22, 2010
    Applicant: The Research Foundation of State University of New York
    Inventors: Li NIU, Zhen HUANG, Hua SHI, John T. LIS
  • Patent number: 7601823
    Abstract: The present invention relates to novel nucleic acid ligands or aptamers that bind to and inhibit the activation of the ?-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors. Also disclosed is a novel combination of technologies, i.e., SELEX and laser pulse photolysis for the selection and screening of aptamers that inhibit receptor function and are useful therefore, in the treatment of diseases associated with excessive activation of ionotropic glutamate receptors.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: October 13, 2009
    Assignees: Cornell University, The Research Foundation of State University of New York
    Inventors: Li Niu, Zhen Huang, Hua Shi, John T. Lis